研究概要
该研究为ARV或UV-ARV致敏的P-PBMCs和CD8 + TILs通过免疫原性凋亡途径杀伤PGC细胞提供了新的见解。我们得出结论,P-PBMCs可以很容易地从GC患者中获取,并作为TILs的丰富来源来杀伤PGC细胞。
研究思路结论见上方概要
背景
胃癌(GC)是包括台湾在内的许多国家的主要恶性疾病,治疗选择有限。动物病毒如溶瘤禽呼肠孤病毒(ARV)有可能避开人体内已有的免疫,同时安全且具有免疫刺激作用。在此,我们提供了一种新的见解,即溶瘤ARV和UV-ARV致敏的患者外周血单核细胞(P-PBMCs)和TIL(肿瘤浸润淋巴细胞)(TILs)通过表面TLR3和TRAIL/DR4/DR5免疫原性凋亡途径杀伤原发性胃癌(PGC)细胞。
方法
我们进行了一项综合研究,旨在揭示ARV或UV灭活的ARV(UV-ARV)调控的P-PBMCs或TILs是否杀伤ARV和UV-ARV致敏的AGS细胞及源自临床患者的PGC细胞,并探讨表面TLR3受体及其上游信号通路的调控。通过流式细胞术和Western blot进行凋亡分析,使用特异性抑制剂抑制信号通路,采用原位邻位连接 assay(PLA)、时间分辨荧光法和乳酸脱氢酶(LDH)细胞毒性试验,并建立体外共培养模型,以研究ARV和UV-ARV致敏的P-PBMCs与TILs杀伤PGC细胞之间的相互作用及其上游通路。
结果
我们的结果揭示,通过TLR3/p38/p53信号通路,ARV和UV-ARV致敏的PGC细胞中DR4和DR5水平升高。重要的是,我们发现ARV或UV-ARV的σC蛋白与CD8+ TILs表面的TLR3相互作用,从而触发TLR3/NF-κB/IFN-γ/TRAIL信号通路,诱导PGC细胞的免疫原性凋亡。本研究进一步揭示了ARV溶瘤的分子基础,并促进ARV或UV-ARV作为癌症治疗手段的应用。
展开英文摘要原文
BACKGROUND: Gastric cancer (GC) is a leading malignant disease in numerous countries, including Taiwan with limited therapeutic options. Animal viruses including oncolytic avian reovirus (ARV) have the possibility to avoid pre-existing immunity in humans, while being safe and immunostimulatory. Here, we provide a novel insight into oncolytic ARV and UV-ARV-sensitized patient's peripheral blood mononuclear cells (P-PBMCs) and tumor infiltrating lymphocytes (TILs) killing primary GC (PGC) cells through the surface TLR3 and TRAIL/DR4/DR5 immunogenic apoptosis pathway.
METHODS: We conducted a comprehensive study to reveal whether ARV- or UV-inactivated ARV (UV-ARV)-modulated P-PBMCs or TILs killing ARV- and UV-ARV-sensitized AGS cells and PGC cells derived from clinical patients and to investigate the regulation of surface TLR3 receptor and upstream signaling pathways. Apoptosis analysis by flow cytometry and Western blot, suppression of signal pathway by specific inhibitors, in situ proximity ligation assay (PLA), time-resolved flurometry and lactate dehydrogenase (LDH) cytotoxicity assays, and an in vitro co-culture model were established to study the interplay between ARV- and UV-ARV-sensitized P-PBMCs and TILs to kill PGC cells and their upstream pathways.
RESULTS: Our results reveal that increased levels of DR4 and DR5 were observed in ARV and UV-ARV sensitized PGC cells through the TLR3/p38/p53 signaling pathway. Importantly, we found that the σC protein of ARV or UV-ARV interacted with surface TLR3 of CD8 + TILs, thereby triggering the TLR3/NF-κB/IFN-γ/TRAIL signaling pathway which induces immunogenic apoptosis of PGC cells. This study sheds further light on the molecular basis behind ARV oncolysis and facilitates the ARV or UV-ARV as a cancer therapeutic.
CONCLUSIONS: The study provides novel insights into ARV- or UV-ARV-sensitized P-PBMCs and CD8 + TILs to kill PGC cells through the immunogenic apoptosis pathway. We conclude that P-PBMCs can easily be obtained from GC patients and provide a rich source as TILs to kill PGC cells.
论文信息
- 作者
- Wu YY、Wu FH、Chen IC、Liao TL、Munir M、Liu HJ
- 第一作者单位
- Institute of Molecular Biology, National Chung Hsing University, Taichung, 402, Taiwan.Taiwan
- 通讯作者单位
- Institute of Molecular Biology, National Chung Hsing University, Taichung, 402, Taiwan. hjliu5257@nchu.edu.tw.Taiwan
- 文献类型
- 非美国政府资助研究
- 期刊
- Cell communication and signaling : CCS2024 Oct 21